Actinium Pharmaceuticals (ATNM) Jumps 39% After Trial Results – Here’s What Investors Should Do…

By |2023-12-07T21:11:07+00:00October 31st, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , |

Actinium Pharmaceuticals (ATNM) is one of the biggest movers early Monday morning. The stock is up 39% for the day after the firm released news that their latest trial results were more than optimistic. The company specializes in developing targeted therapies for cancer. Their therapies are known as antibody radiation conjugates - a special [...]